Global Indian Nasal Spray Market Size study, by Product (Decongestion Nasal Spray, Salt Water Solution/Saline Nasal Spray, Steroid Nasal Spray). by Availability (Prescribed, Over the Counter), by Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitors, Anticholinergic) and by Regional Forecasts 2018-2025
-
Product Code:
RP-ID-10012848 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
180 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-14
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Indian Nasal Spray Market to reach USD 1.65 billion by 2025.
Global Indian Nasal Spray Market valued approximately USD 786 million in 2017 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2018-2025. The primary factors driving the market growth of Indian Nasal include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. About 20-30% of Indian population suffers from at least one allergic disease. On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.
The regional analysis of Global Indian Nasal Spray Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Decongestion Nasal Spray
 Salt Water Solution/Saline Nasal Spray
 Steroid Nasal Spray
By Availability:
 Prescribed
 Over the Counter
By Therapeutic Class:
 Antihistamine
 Nasal Steroids
 Mast Cell Inhibitor
 Anticholinergic
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Glaxo Smith Kline, Ranbaxy., Cipla, Lupin, Sun pharmaceuticals Industries Ltd., Zydus Cadiala Pharmaceuticals, Macleods and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Indian Nasal Spray Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
Ranbaxy.
Cipla
Lupin
Sun pharmaceuticals Industries Ltd.
Zydus Cadiala Pharmaceuticals
Macleods